The Union Budget 2026–27 has once again placed the spotlight on the pharmaceutical sector, underscoring the government’s commitment to strengtheni...
India’s Biopharma Revolution: How the Union Budget 2026’s “Biopharma SHAKTI” Scheme Could Transform Healthcare
The Union Budget 2026–27, presented by Finance Minister Nirmala Sitharaman, made waves for its bold focus on healthcare innovation, especially throu...
Revolutionizing India’s Pharma Landscape: How the Government Has Trimmed Trial Burden on New Drugs
In a landmark move that could reshape the Indian pharmaceutical industry, the Union Health Ministry has announced significant regulatory amendments to...
When Medicines Turn Deadly: Why India’s Crackdown on Cough Syrups Signals a New Era of Drug Safety
In recent months, India has faced a sobering reminder of the critical gaps in its pharmaceutical oversight. The deaths of children linked to contamina...
From Dreams to Glory: The Rise of Indian Women’s Cricket and the 2025 World Cup Triumph
🏏 A Triumph That Inspires a Nation A golden day for Indian sport! The Indian Women’s National Cricket Team has created history — on 2 November ...
Trump’s Executive Orders and Their Impact on Indian Pharma Companies
The Indian pharmaceutical industry has long served as a vital player in global healthcare, providing cost-effective generic medicines to markets world...
Array
